Beam Therapeutics (BEAM) Non Operating Income (2020 - 2026)

Beam Therapeutics (BEAM) has 7 years of Non Operating Income data on file, last reported at $12.9 million in Q1 2026.

• Quarterly Non Operating Income rose 17.72% year-over-year to $12.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $306.6 million (up 591.15% YoY) and the FY2025 annual result came in at $303.7 million, up 681.43% from the prior year.
• Non Operating Income declined to $12.9 million in Q1 2026 per BEAM's latest filing, from $261.7 million in the prior quarter.
• Across five years, Non Operating Income topped out at $261.7 million in Q4 2025 and bottomed at $2.5 million in Q1 2023.
• The 5-year median for Non Operating Income is $11.3 million (2023), against an average of $28.2 million.
• The widest annual swing landed in 2022, when Non Operating Income jumped 4322.08%; it then plunged 78.11% in 2023.
• Tracing BEAM's Non Operating Income over 5 years: stood at $51.6 million in 2022, then sank by 78.11% to $11.3 million in 2023, then fell by 14.35% to $9.7 million in 2024, then jumped by 2603.11% to $261.7 million in 2025, then slumped by 95.07% to $12.9 million in 2026.
• Per Business Quant, the three latest BEAM Non Operating Income figures stand at $12.9 million (Q1 2026), $261.7 million (Q4 2025), and $14.1 million (Q3 2025).

Peer Comparison